Phadia AB is a company based in Uppsala that specializes in the development and production of diagnostic solutions for allergy and autoimmune diseases. The organization is known for its innovative technologies and products, which are used in laboratories and healthcare settings worldwide. Phadia's offerings include a range of immunoassays and diagnostic systems that help healthcare professionals diagnose and manage various conditions related to allergies and autoimmune disorders.
The company has a strong focus on research and development, continually working to enhance its product line and improve diagnostic accuracy. Phadia AB is part of a larger network of companies and institutions dedicated to advancing medical diagnostics, contributing to the overall understanding and treatment of allergic and autoimmune diseases. Its commitment to quality and innovation has positioned it as a significant player in the healthcare diagnostics market.